Xencor



Ebitda Cambiamento Data
AbbVie USD 6.92B 258M 2024-12
Alnylam Pharmaceuticals USD 32.48M 123.47M 2025-03
Amgen USD 3.75B 42M 2025-03
Arrowhead Research USD -156177000 1M 2024-12
AstraZeneca USD 5.08B 182M 2025-03
Biogen USD 754.8M 7.2M 2024-12
Bristol-Myers Squibb USD 4.9B 16M 2025-03
Cytokinetics USD -136657000 1.73M 2024-12
GlaxoSmithKline GBP 3.14B 1.06B 2025-03
J&J USD 7.88B 1.76B 2025-03
MacroGenics USD -50784000 106.81M 2024-12
Merck USD 7.74B 625M 2025-03
Novartis USD 5.19B 319M 2024-12
Pfizer USD 6.21B 1.5B 2025-03
Regeneron Pharmaceuticals USD 730.9M 324.8M 2025-03
Roche Holding CHF 12.68B 2.36B 2024-06
Xencor USD 7.14M 64.97M 2024-12



Xencor - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.